Top Abstract Purchase Related
Home
>
Node
>
Subnode

Clinical trial of UFT against disseminated breast cancer

Itoh, S.; Konishi, Y.; Harauchi, D.; Shinoto, M.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(11): 2381-2385

1984

ISSN/ISBN: 0385-0684
PMID: 6437344
Document Number: 228962
A study was carried out in 32 patients with disseminated breast cancer to determine the clinical responses and side-effects of daily administration of 400-600 mg of UFT. According to the Japan Mammary Cancer Society's criteria of response, more than partial response was observed in 11 out of 32 cases (34.4%). Side-effects were observed in 15 cases (46.9%) and these mainly consisted of those involving slight myelosuppression and upper digestive organs, such us nausea and anorexia.

Document emailed within 1 workday
Secure & encrypted payments

Fetting, J.H.; Siminoff, L.A.; Piantadosi, S.; Abeloff, M.D.; Damron, D.J.; Sarsfield, A.M. 1990: Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(9): 1476-1482
Morimoto, T.; Komaki, K.; Yamakawa, T.; Tanaka, T.; Konishi, Y.; Uomine, Y.; Miki, H.; Ooshimo, K.; Monden, Y. 1988: Clinical trial of 5'-DFUR in patients with recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(10): 2983-2989
Liu, X.; Song, S.; Jiang, Z.; Wu, S.; Yu, J.; Wang, T. 2002: Clinical trial of lentaron for postmenopausal patients with advanced breast cancer Zhonghua Zhong Liu Za Zhi 24(5): 511-513
Pannuti, F.; Martoni, A.; Piana, E.; Tomasi, L.; Grieco, A.; Farris, A.; Saccani, F.; Baroni, M. 1984: Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(4): 211-215
Vetter, C. 2003: So that survival chances in breast cancer are improved. Finding a "clinical trial opportunity" for your patients MMW Fortschritte der Medizin 145(16): 14
Takatsuka, Y.; Shin, E.; Kikkawa, N. 1996: A clinical trial of neoadjuvant intraarterial chemotherapy for the treatment of locally advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1523-1525
Siegel, M.B.; Van Swearingen, A.E.D.; Anders, C.K. 2014: Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis Oncology 28(7): 579; 584-585
Dar, U.K.; Khan, I.U.; Javed, M.; Rasheed, R.; Mahmoud, Z.; Hyder, S.W.; Bhatti, S.M.; Anwar, J. 2012: Preperation of (99m)Tc labeled 5-fluorouracil as a potential diagnostic agent in advanced breast cancer: first clinical trial Hellenic Journal of Nuclear Medicine 15(1): 43-47
Berndt, H.; Eichhorn, J.H.; Widow, W. 1980: A controlled clinical trial on adjuvant therapy by preoperative irradiation or postoperative cyclophosphamide in breast cancer Archiv für Geschwulstforschung 50(5): 468-479
1999: 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer Lancet 353(9168): 1909-1914
Gershanovich, M.L.; Garin, A.M.; Baltinia, D.; Kurvet, A.; Kangas, L.; Ellmen, I. 1997: Results of phase Ii clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women Voprosy Onkologii 43(6): 587-595
Rosselli Del Turco, M.; Palli, D.; Cariddi, A.; Ciatto, S.; Pacini, P.; Distante, V. 1994: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up JAMA 271(20): 1593-1597
Voznyĭ, E.K.; Meshcheriakova, N.G.; Biakhov, M.I.; Vasiuta, N.I. 1990: Hormonal control of disseminated breast cancer Sovetskaia Meditsina 6: 94-97
Giles, K.; Flynn, P.J.; Dalton, R.; Zera, R. 1993: National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial Minnesota Medicine 76(12): 25-27
Rainer, H. 1985: Prospective randomized clinical trial: protoadjuvant chemotherapy vs. protoadjuvant radiotherapy in breast cancer stages T3/4, N+/-, M0 Wiener Medizinische Wochenschrift 135(23-24): 599-602
Bradley, J.A.; Dagan, R.; Ho, M.Wei.; Rutenberg, M.; Morris, C.G.; Li, Z.; Mendenhall, N.P. 2016: Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons International Journal of Radiation Oncology Biology Physics 95(1): 411-421
Sopkova, V.; Mechl, Z. 1986: Cisplatin (platidiame) in the treatment of patients with disseminated breast cancer Voprosy Onkologii 32(4): 36-38
Pauporte, I.; Faure, C.; Pivot, X. 2009: Impulser la recherche clinique française dans le cancer du sein: l'exemple de l'essai PHARE : Réflexions sur la recherche clinique en France - How to strengthen the French breast cancer clinical research: the example of the PHARE trial Oncologie (Paris) 11(6): 348-352
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Marinov, L.; Tsekova, V.; Koĭnov, K.; Velikova, M.; Micheva, D. 1987: Drostanolone propionate (masteril) in disseminated breast cancer in women. Immediate results Khirurgiia 40(6): 80-86